342 related articles for article (PubMed ID: 21729753)
1. Endocrine-active chemicals in mammary cancer causation and prevention.
Jenkins S; Betancourt AM; Wang J; Lamartiniere CA
J Steroid Biochem Mol Biol; 2012 Apr; 129(3-5):191-200. PubMed ID: 21729753
[TBL] [Abstract][Full Text] [Related]
2. Altered carcinogenesis and proteome in mammary glands of rats after prepubertal exposures to the hormonally active chemicals bisphenol a and genistein.
Betancourt AM; Wang J; Jenkins S; Mobley J; Russo J; Lamartiniere CA
J Nutr; 2012 Jul; 142(7):1382S-8S. PubMed ID: 22649256
[TBL] [Abstract][Full Text] [Related]
3. Gestational exposure to the AhR agonist 2,3,7,8-tetrachlorodibenzo-p-dioxin induces BRCA-1 promoter hypermethylation and reduces BRCA-1 expression in mammary tissue of rat offspring: preventive effects of resveratrol.
Papoutsis AJ; Selmin OI; Borg JL; Romagnolo DF
Mol Carcinog; 2015 Apr; 54(4):261-9. PubMed ID: 24136580
[TBL] [Abstract][Full Text] [Related]
4. Prenatal exposure to bisphenol A promotes angiogenesis and alters steroid-mediated responses in the mammary glands of cycling rats.
Durando M; Kass L; Perdomo V; Bosquiazzo VL; Luque EH; Muñoz-de-Toro M
J Steroid Biochem Mol Biol; 2011 Oct; 127(1-2):35-43. PubMed ID: 21513798
[TBL] [Abstract][Full Text] [Related]
5. In utero exposure to diethylstilbestrol (DES) or bisphenol-A (BPA) increases EZH2 expression in the mammary gland: an epigenetic mechanism linking endocrine disruptors to breast cancer.
Doherty LF; Bromer JG; Zhou Y; Aldad TS; Taylor HS
Horm Cancer; 2010 Jun; 1(3):146-55. PubMed ID: 21761357
[TBL] [Abstract][Full Text] [Related]
6. Xenoestrogens alter mammary gland differentiation and cell proliferation in the rat.
Brown NM; Lamartiniere CA
Environ Health Perspect; 1995; 103(7-8):708-13. PubMed ID: 7588483
[TBL] [Abstract][Full Text] [Related]
7. Cell proliferation and apoptosis in rat mammary glands following combinational exposure to bisphenol A and genistein.
Wang J; Jenkins S; Lamartiniere CA
BMC Cancer; 2014 May; 14():379. PubMed ID: 24884420
[TBL] [Abstract][Full Text] [Related]
8. Genistein and resveratrol: mammary cancer chemoprevention and mechanisms of action in the rat.
Whitsett TG; Lamartiniere CA
Expert Rev Anticancer Ther; 2006 Dec; 6(12):1699-706. PubMed ID: 17181483
[TBL] [Abstract][Full Text] [Related]
9. Perinatal Exposure to Bisphenol A or Diethylstilbestrol Increases the Susceptibility to Develop Mammary Gland Lesions After Estrogen Replacement Therapy in Middle-Aged Rats.
Gomez AL; Delconte MB; Altamirano GA; Vigezzi L; Bosquiazzo VL; Barbisan LF; Ramos JG; Luque EH; Muñoz-de-Toro M; Kass L
Horm Cancer; 2017 Apr; 8(2):78-89. PubMed ID: 28078498
[TBL] [Abstract][Full Text] [Related]
10. Exposure to Endocrine Disrupting Chemicals and Risk of Breast Cancer.
Eve L; Fervers B; Le Romancer M; Etienne-Selloum N
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33266302
[TBL] [Abstract][Full Text] [Related]
11. [Endocrine disrupting chemicals and carcinogenesis--breast, testis and prostate cancer].
Imaida K; Shirai T
Nihon Rinsho; 2000 Dec; 58(12):2527-32. PubMed ID: 11187749
[TBL] [Abstract][Full Text] [Related]
12. Endocrine-disrupting compounds and mammary gland development: early exposure and later life consequences.
Fenton SE
Endocrinology; 2006 Jun; 147(6 Suppl):S18-24. PubMed ID: 16690811
[TBL] [Abstract][Full Text] [Related]
13. Hormone receptor expression in aging mammary tissue and carcinoma from a rodent model after xenoestrogen disruption.
Ruiz TFR; Colleta SJ; Zuccari DAPC; Vilamaior PSL; Leonel ECR; Taboga SR
Life Sci; 2021 Nov; 285():120010. PubMed ID: 34606849
[TBL] [Abstract][Full Text] [Related]
14. Estrogens in the wrong place at the wrong time: Fetal BPA exposure and mammary cancer.
Paulose T; Speroni L; Sonnenschein C; Soto AM
Reprod Toxicol; 2015 Jul; 54():58-65. PubMed ID: 25277313
[TBL] [Abstract][Full Text] [Related]
15. Genistein studies in rats: potential for breast cancer prevention and reproductive and developmental toxicity.
Lamartiniere CA; Zhang JX; Cotroneo MS
Am J Clin Nutr; 1998 Dec; 68(6 Suppl):1400S-1405S. PubMed ID: 9848507
[TBL] [Abstract][Full Text] [Related]
16. Bisphenol-A: a new diabetogenic factor?
Alonso-Magdalena P; Ropero AB; Soriano S; Quesada I; Nadal A
Hormones (Athens); 2010; 9(2):118-26. PubMed ID: 20687395
[TBL] [Abstract][Full Text] [Related]
17. In utero estrogenic endocrine disruption alters the stroma to increase extracellular matrix density and mammary gland stiffness.
Wormsbaecher C; Hindman AR; Avendano A; Cortes-Medina M; Jones CE; Bushman A; Onua L; Kovalchin CE; Murphy AR; Helber HL; Shapiro A; Voytovitch K; Kuang X; Aguilar-Valenzuela R; Leight JL; Song JW; Burd CJ
Breast Cancer Res; 2020 May; 22(1):41. PubMed ID: 32370801
[TBL] [Abstract][Full Text] [Related]
18. Bisphenol A (BPA) Exposure In Utero Leads to Immunoregulatory Cytokine Dysregulation in the Mouse Mammary Gland: A Potential Mechanism Programming Breast Cancer Risk.
Fischer C; Mamillapalli R; Goetz LG; Jorgenson E; Ilagan Y; Taylor HS
Horm Cancer; 2016 Aug; 7(4):241-51. PubMed ID: 26911702
[TBL] [Abstract][Full Text] [Related]
19. Biochemical and molecular changes at the cellular level in response to exposure to environmental estrogen-like chemicals.
Roy D; Palangat M; Chen CW; Thomas RD; Colerangle J; Atkinson A; Yan ZJ
J Toxicol Environ Health; 1997 Jan; 50(1):1-29. PubMed ID: 9015129
[TBL] [Abstract][Full Text] [Related]
20. Progesterone and Overlooked Endocrine Pathways in Breast Cancer Pathogenesis.
Brisken C; Hess K; Jeitziner R
Endocrinology; 2015 Oct; 156(10):3442-50. PubMed ID: 26241069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
